Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, ...

BioAtla (BCAB) announced preclinical poster presentations at the upcoming 2025 American Association for Cancer Research to be held at the ...

Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and ...

Meet a go-getter reaching well beyond the classroom and his chosen course of study to capitalize on diverse experiences. He ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data from its Phase 2a clinical ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that 18 abstracts, including one oral presentation, have ...

Details of the acimtamig oral presentation and AFM24 poster presentations are as follows: The full abstracts will be published online on May 22, 2025. More details about the programs for the 2025 ASCO ...

"Korea has an acute challenge” when it comes to long-term relationships, notes Malgosia Green, Asia CEO for Match.

The abstracts will be available on the ASCO® website on May 22, 2025 at 5:00 p.m. ET. The full presentation will be available on the Merus website at the start of the session.

Abstracts for oral and poster presentations are now being accepted for the 2025 Western Regional Meeting. The meeting will take place October 25–28 at the Signia by Hilton Hotel in San Jose, ...

UC Davis student Natasha Bibbs of Sacramento has already gone places with academic research — and she hopes to go even ...